Clinical trials
Phase 2 Fragile X Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Novartis Pharmaceuticals | 3 |
| Seaside Therapeutics, Inc. | 3 |
| Elizabeth Berry-Kravis | 2 |
| Indiana University | 2 |
| Stanford University | 2 |
| Alcobra Ltd. | 1 |
| Azevan Pharmaceuticals | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Craig Erickson | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fragile X Syndrome | 28 |
| Autistic Disorder | 4 |
| Genetic Diseases, Inborn | 4 |
| Autism Spectrum Disorder | 2 |
| Mental Disorders | 2 |
| Anxiety Disorders | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cognition Disorders | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.